Home > PS Ratio > MERCURY LABORATORIES

MERCURY LABORATORIES
PS (Price/Sales) Ratio

The Current P/S Ratio of MERCURY LABORATORIES is 1.72.

Share Price ₹1,057.0Sep 13,2024
Market Cap ₹126.8 Cr
Sales-TTM₹73.9 CrTTM-Standalone Results
Price/Sales1.72xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for MERCURY LABORATORIES
Please provide your vote to see the results
MERCURY LABORATORIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of MERCURY LABORATORIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of MERCURY LABORATORIES is calculated as :

Current Market Cap [ ₹126.8 Cr] as on Sep 13,2024

(/) Sales [ ₹73.9 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 1.72x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for MERCURY LABORATORIES , the investors are currently willing to pay '1.72 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of MERCURY LABORATORIES !

The chart below summarizes the trend in P/S Ratio of MERCURY LABORATORIES over the last five years.

Historical PS (Price/Sales) ratio chart of MERCURY LABORATORIES


PS Ratio Performance Analysis for MERCURY LABORATORIES

- MERCURY LABORATORIES 's latest p/e ratio is 1.72x.

- MERCURY LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.87x.

- MERCURY LABORATORIES 's operated at median p/e ratio of 0.93x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MERCURY LABORATORIES 's p/e ratio peaked in Mar2021 at 1.12x.

- MERCURY LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 0.59x.


How does MERCURY LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
MERCURY LABORATORIES 73.91.72126.8
SUN PHARMACEUTICAL INDUSTRIES LTD49,208.89.04444,825.0
CIPLA LTD26,139.15.13133,996.0
DR REDDYS LABORATORIES LTD28,949.33.84111,112.0
ZYDUS LIFESCIENCES LTD20,615.35.46112,547.0
DIVIS LABORATORIES LTD8,185.017.82145,892.0
MANKIND PHARMA LTD10,649.69.40100,111.0
TORRENT PHARMACEUTICALS LTD10,996.010.64116,955.0
LUPIN LTD20,797.14.94102,793.0
AUROBINDO PHARMA LTD29,718.43.0691,046.5
ABBOTT INDIA LTD5,927.510.6062,819.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MERCURY LABORATORIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.72x
Max industry PS 17.82x
Median industry PS 5.46x
Average industry PS 7.42x



You may also like the below Video Courses